HLA-DR antigen expression on colorectal carcinomas: influence of expression by IFN-? in situ and its association with tumour progression
1996

HLA-DR Antigen Expression in Colorectal Carcinomas

Sample size: 49 publication Evidence: moderate

Author Information

Author(s): K Matsushita, T Takenouchi, S Kobayashi, H Hayashi, K Okuyama, T Ochiai, A Mikata, K Isono

Primary Institution: Chiba University School of Medicine

Hypothesis

The study investigates the host's immune response against colorectal carcinoma through HLA-DR antigen expression.

Conclusion

HLA-DR antigen expression on carcinoma cells and adjacent normal epithelia is associated with less advanced tumor stages.

Supporting Evidence

  • HLA-DR antigen was expressed in 55.1% of carcinoma cells and 75.5% of adjacent normal epithelia.
  • Patients with HLA-DR staining were in less advanced Dukes' stages.
  • Detection of IFN-y mRNA was associated with HLA-DR antigen expression.

Takeaway

The study found that certain markers in cancer cells can show how well the body's immune system is fighting the cancer.

Methodology

The study used immunohistochemistry to examine HLA-DR antigen expression and RT-PCR to detect mRNAs of cytokines in tissue samples.

Participant Demographics

49 Japanese patients (35 men and 14 women, age 35-84 years, average 61.3 years) with colorectal adenocarcinomas.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication